Get started
Author

Su‐Mei Cao

Observed names: Cao, Su-Mei, S. Cao, S.M. Cao, Su-Mei Cao, Su-mei Cao, SuMei CAO, Sumei Cao
Observed institutions: Sun Yat-sen University, Guangdong Medical College, World Health Organization, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangzhou Medical University
ORCID: 0000-0003-1925-1208
Observed ORCIDs: 0000-0003-1925-1208, 0000-0003-1749-517X
OpenAlex ID: A5035797333
Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?
2019 · Rui‐Mei Feng, Yi‐Nan Zong, et al. · 癌症：英文版 · 1,625
PDF
Cancer incidence, mortality, and burden in China: a time‐trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020
2021 · Haibo Qiu, Sumei Cao, et al. · 癌症：英文版 · 1,016
PDF
Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer
2020 · Huiyan Luo, Qi Zhao, et al. · Science Translational Medicine · 438
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial
2017 · Su-Mei Cao, Qi Yang, et al. · European Journal of Cancer · 279
Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trial
2019 · Qi Yang, Su-Mei Cao, et al. · European Journal of Cancer · 227
An Epidemiological and Molecular Study of the Relationship Between Smoking, Risk of Nasopharyngeal Carcinoma, and Epstein–Barr Virus Activation
2012 · Feng-Hua Xu, Dan Xiong, et al. · JNCI Journal of the National Cancer Institute · 209
Incidence and mortality of nasopharyngeal carcinoma: interim analysis of a cluster randomized controlled screening trial (PRO-NPC-001) in southern China
2019 · M.F. Ji, W. Sheng, et al. · Annals of Oncology · 168
Fluctuations of Epstein-Barr Virus Serological Antibodies and Risk for Nasopharyngeal Carcinoma: A Prospective Screening Study with a 20-Year Follow-Up
2011 · Su-Mei Cao, Zhiwei Liu, et al. · PLoS ONE · 165
PDF
Induction Chemotherapy plus Concurrent Chemoradiotherapy in Endemic Nasopharyngeal Carcinoma: Individual Patient Data Pooled Analysis of Four Randomized Trials
2018 · Yu-Pei Chen, Ling-Long Tang, et al. · Clinical Cancer Research · 161
Incidence trend of nasopharyngeal carcinoma from 1987 to 2011 in Sihui County, Guangdong Province, South China: an age-period-cohort analysis
2015 · Li-Fang Zhang, Yan-Hua Li, et al. · 癌症：英文版 · 154
PDF
Establishment of VCA and EBNA1 IgA‐based combination by enzyme‐linked immunosorbent assay as preferred screening method for nasopharyngeal carcinoma: a two‐stage design with a preliminary performance study and a mass screening in southern China
2011 · Yue Liu, Qihong Huang, et al. · International Journal of Cancer · 151
Nasopharyngeal Cancer Incidence and Mortality in 185 Countries in 2020 and the Projected Burden in 2040: Population-Based Global Epidemiological Profiling
2023 · Yanting Zhang, Harriet Rumgay, et al. · JMIR Public Health and Surveillance · 136
PDF
The Epidemiology of Nasopharyngeal Carcinoma
2010 · Jun Ma, Sumei Cao · Medical radiology · 112
Active and Passive Smoking and Risk of Nasopharyngeal Carcinoma: A Population-Based Case-Control Study in Southern China
2017 · Ellen T. Chang, Zhiwei Liu, et al. · American Journal of Epidemiology · 111
PDF
Evaluation of plasma Epstein‐Barr virus DNA load to distinguish nasopharyngeal carcinoma patients from healthy high‐risk populations in Southern China
2014 · Ming‐Fang Ji, Qi‐Hong Huang, et al. · Cancer · 86
PDF
Elevation of serum vascular endothelial growth factor in male patients with metastatic nasopharyngeal carcinoma
2000 · Chao-Nan Qian, Chang-Qing Zhang, et al. · Cancer · 80
PDF
Quantification of familial risk of nasopharyngeal carcinoma in a high‐incidence area
2017 · Zhiwei Liu, Ellen T. Chang, et al. · Cancer · 78
PDF
A randomized trial of induction chemotherapy plus concurrent chemoradiotherapy versus induction chemotherapy plus radiotherapy for locoregionally advanced nasopharyngeal carcinoma
2012 · Pei-Yu Huang, Ka-Jia Cao, et al. · Oral Oncology · 74
Prognostic Value of Survivin and Livin in Nasopharyngeal Carcinoma
2006 · Yanqun Xiang, Herui Yao, et al. · The Laryngoscope · 71
Global trends and epidemiological shifts in gastrointestinal cancers: insights from the past four decades
2025 · Mengmeng Li, Sumei Cao, et al. · 癌症：英文版 · 69
Recommendations for Epstein-Barr virus–based screening for nasopharyngeal cancer in high- and intermediate-risk regions
2023 · W K Jacky Lam, Ann D King, et al. · JNCI Journal of the National Cancer Institute · 61
PDF
Oral Hygiene and Risk of Nasopharyngeal Carcinoma—A Population-Based Case–Control Study in China
2016 · Zhiwei Liu, Ellen T. Chang, et al. · Cancer Epidemiology Biomarkers & Prevention · 60
Centromere Protein H Is a Novel Prognostic Marker for Nasopharyngeal Carcinoma Progression and Overall Patient Survival
2007 · Wen-Ting Liao, Li-Bing Song, et al. · Clinical Cancer Research · 56
A polygenic risk score for nasopharyngeal carcinoma shows potential for risk stratification and personalized screening
2022 · Yong-Qiao He, Tong-Min Wang, et al. · Nature Communications · 53
PDF
A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus
2021 · Qian-Ying Zhu, Sisi Shan, et al. · Nature Communications · 53
PDF
Works count: 135
Citation count: 7,172
H-index: 36
I10-index: 76
Year
Topic
Type